David J. Lockhart
2013
In 2013, David J. Lockhart earned a total compensation of $991.1K as Chief scientific officer at Amicus Therapeutics, a 12% decrease compared to previous year.
Compensation breakdown
| Bonus | $135,756 |
|---|---|
| Option Awards | $427,373 |
| Salary | $401,807 |
| Other | $26,119 |
| Total | $991,055 |
Lockhart received $427.4K in option awards, accounting for 43% of the total pay in 2013.
Lockhart also received $135.8K in bonus, $401.8K in salary and $26.1K in other compensation.
Rankings
In 2013, David J. Lockhart's compensation ranked 6,653rd out of 12,286 executives tracked by ExecPay. In other words, Lockhart earned more than 45.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,653 out of 12,286 | 46th |
Division Manufacturing | 2,343 out of 4,612 | 49th |
Major group Chemicals And Allied Products | 696 out of 1,462 | 52nd |
Industry group Drugs | 508 out of 1,156 | 56th |
Industry Pharmaceutical Preparations | 403 out of 890 | 55th |
Source: SEC filing on April 28, 2014.
Lockhart's colleagues
We found four more compensation records of executives who worked with David J. Lockhart at Amicus Therapeutics in 2013.